Fetal Maternal Hemorrhage by Flow Cytometry

Test Description

Quantifying fetal red blood cells in Rh-negative mothers plays a crucial role in assessing the risk of hemolytic disease of the fetus and newborn (HDFN), most often caused by Rh incompatibility. The utility of this test is to determine the dosing for Rh immunoglobulin (RhIg) administration to prevent sensitization and protect future pregnancies. Additionally, this test can quantify fetomaternal hemorrhage in obstetric trauma.

Test Type

Hemoglobin F detection

Additional Test Name(s)

Hemoglobin F detection in maternal blood sample

Sample Notes

Whole blood (EDTA or ACD). Do not centrifuge or separate. Must be submitted in the original collection tube. Note: Samples should be tested within 3 days of collection.